Kuala Lumpur, 28 November 2023 – KPJ Healthcare Berhad (“KPJ Healthcare” or the “Group”), once again delivers a stellar financial performance for quarter three ended 30 September 2023 (“Q3 FY2023”).
KPJ Healthcare reported revenue of RM925.4 million for Q3 FY2023, a 16.0% increase as compared to RM798.7 million in the third quarter of Financial Year 2022 (“Q3 FY2022”). The Group’s Profit After Tax (“PAT”) and Profit Before Tax (“PBT”) of RM97.3 million and RM133.1 million respectively, is an increase of 71.0% and 50.0%.
The Group demonstrated a commendable growth of 29.0% in Earnings Before Interest, Taxes, Depreciation, and Amortisation (“EBITDA”), reaching RM254.8 million in the third quarter of FY2023, as compared to RM198.1 million in Q3 FY2022.
This achievement was largely attributed to a significant rise in inpatient visits, totaling 96,968 in Q3 FY2023, up from 85,655 in Q3 FY2022. The Bed Occupancy Rate (“BOR”) has experienced a noteworthy rise, increasing from 66% to 73%, thereby contributing to the robust financial accomplishments of the Group.
Due to its formidable performance, KPJ Healthcare has declared an interim dividend of 1.05 sen per share and a special dividend of 0.25 sen per share, amounting to a total aggregate payment of RM56.7 million to be disbursed to the shareholders of KPJ Healthcare on 28 December 2023. The declaration of the special dividend arises from the completion of divestment of its interest in all entities in Indonesia’s region as part of its strategic plan to place greater focus on the Group’s core Malaysia segment.
“Our record-breaking quarter is a powerful indicator of the Group’s strategic agility and the relentless drive of our team,” statedChin Keat Chyuan, President and Managing Director of KPJ Healthcare. “These achievements are just the beginning. Our roadmap for 2024 will see us deepening operational efficiencies, embracing digital transformation, and solidifying our leadership in health tourism.
“The divestment of our Indonesian hospitals is a strategic move, which will allow us to focus on our core businesses within the domestic market,” Chin continued. “This decision aligns with our broader financial strategy to sharpen our focus on the Malaysian market, where we see the greatest potential for growth and innovation. By streamlining our portfolio in this way, we are positioned to direct our resources and investments more effectively. This approach is key to ensuring that KPJ Healthcare not only maintains its current momentum but also accelerates its performance in both financial and healthcare excellence. The strategic realignment of our operations is fundamental to our ongoing pursuit of superior healthcare innovation and to enhancing the value we deliver to our shareholders and patients.”
Through these focused efforts, KPJ Healthcare is dedicated to advancing healthcare standards, enhancing operational performance, and driving innovation, all while maintaining a steadfast commitment to sustainability and social responsibility.
